Nice PR. They take a PR from Biken saying they will expand their production capabilities for existing vaccine (that has no Ampligen in it).
Then they tack on their own paragraph that is designed to get the YahooHebHeads to think they will be using Ampligen for the Swine Flu run this summer.
AFAIK, Apmligen was only tried in a human flu trial as an adjunt once (a 2007 P2 trial in Australia). No results were disclosed, so it obviously failed. Not that I would bother searching hard for anything on this junk.
I would guess the timing of this PR virtually guarantees that the FDA CR letter will be disclosed about 8:00EST tonight.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.